The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Fundacion Distonia (Dystonia)
Avda. Irarrázaval 5185
The Fundacion Distonia (Dystonia) is a non-profit organization in Chile dedicated to providing information, support, and resources to individuals affected by dystonia, a group of neuromuscular disorders characterized by abnormal muscle rigidity that results in involuntary muscle spasms, abnormal movement patterns, and/or unusual fixed positioning of affected muscles. Dystonia may involve a particular area of the body (focal dystonia) or may be more generalized. Fundacion Distonia was established in 1997 and currently consists of approximately 145 members. The organization is committed to promoting awareness of dystonia among affected individuals and family members, health care professionals, and the general public; engaging in patient advocacy; and conducting support groups for individuals with dystonia and their family members. Fundacion Distonia also has a program to provide free botulinum toxin therapy to affected individuals who cannot otherwise afford such treatment. During such therapy, minute amounts of a toxin produced by the bacteria Clostridium botulinum (botulinum toxin) are injected directly into affected muscles, causing temporary muscular paralysis, thereby preventing spasms and abnormal contraction associated with dystonia. Fundacion Distonia also has informational brochures, a regular newsletter, and a web site on the Internet. The organization's materials are provided in Spanish and French.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.